The ISO 5833 Surgical Implants - Acrylic Resin Cements standard, published by the International Organization for Standardization (ISO), describes the physical, mechanical, packing, and labeling requirements for curing poly(methacrylic acid esters) based, radiopaque and non-radiopaque polymerized resin cements. This standard applies to two types of cements used for fixation of internal orthopedic prostheses, designed for use via syringe or in paste form, and supplied in pre-measured quantities of sterile powder and sterile liquid in forms suitable for mixing during implantation.
The ISO 5833 standard does not cover hazards that may arise for patients or cement users in relation to the use of cement. All requirements apply to sterile products, and all tests must be performed on sterile products.
ISO 5833 is an international standard that specifies the requirements for acrylic resin cements used in the fixation of internal orthopedic prostheses. These materials are commonly known as acrylic bone cements and are used to fix orthopedic implants to bone during surgical procedures.
The primary purpose of the ISO 5833 standard is to define consistent physical, mechanical, packaging, and labeling requirements for acrylic resin cements used in orthopedic surgery. These cements are typically supplied as two sterile components:
The components are mixed immediately before implantation. Depending on the product and intended use, the cement may be designed to be applied via syringe or in a paste consistency. The standard covers both:
The cements covered are poly(methacrylic acid esters) based, including the commonly used polymethyl methacrylate (PMMA) based formulations.
Acrylic bone cement is primarily used to provide fixation between orthopedic prostheses and the surrounding bone. Typical applications include:
Cement is mixed during surgery and undergoes polymerization, transforming from a workable mixture into a hardened material. The resulting cement coating helps transfer load between the implant and the bone.
The ISO 5833 standard addresses various key properties of acrylic resin cement. This standard specifies the requirements regarding the physical behavior of the cement during preparation and curing. Key properties include:
These features are important because the surgeon needs sufficient time to prepare and position the cement and implant before the cement fully hardens.
Cement must possess adequate mechanical properties after curing. Mechanical evaluation is important because the cement is subjected to repeated loads after implantation. Therefore, the standard addresses the following properties:
The aim is to ensure that the cement possesses the appropriate mechanical properties for the intended orthopedic application.
Some acrylic bone cements contain radiopaque components. Radiopacity is important because it allows the cement covering to be distinguished from the surrounding bone and other structures during radiographic examination. Therefore, the ISO 5833 standard distinguishes between them:
This feature may be important for postoperative evaluation and monitoring of the implant-cement-bone interface.
The ISO 5833 standard is not limited to the material properties of cement. It also specifies requirements related to packaging and labeling. Cement is supplied as sterile powder and liquid in pre-measured quantities suitable for mixing during implantation. This is important because contamination, incorrect component ratios, or component degradation can affect:
This standard specifies that its requirements and tests apply to sterile products.
Typical performance areas assessed using the ISO 5833 standard include:
The ISO 5833 standard is important because bone cement is a load-bearing component of an orthopedic fixation system. Cement with inadequate mechanical or processing properties can lead to problems such as:
ISO 5833 provides manufacturers and laboratories with a common framework for evaluating acrylic resin cements by establishing standardized requirements and test methods. It also increases comparability between products and batches.
A key limitation is that the ISO 5833 standard does not cover all hazards arising from the use of acrylic resin cement in relation to the patient or user. This standard explicitly excludes such hazards. Therefore, compliance with the ISO 5833 standard should not, in itself, imply full clinical safety or regulatory approval. Manufacturers may need to address additional requirements regarding the following:
In conclusion, the ISO 5833 standard addresses the important physical and mechanical properties of sterile, radiopaque, and non-radiopaque acrylic resin cements, as well as packaging and labeling issues. Its fundamental value lies in providing a standardized basis for ensuring that bone cement possesses predictable performance, hardening, mechanical, and product quality characteristics before being used in orthopedic implant fixation. In short, the ISO 5833 standard helps ensure that acrylic bone cement is manufactured and tested with suitable, consistent performance characteristics for orthopedic implant fixation.
For many years, our organization, with its competent and experienced staff, has been understanding the needs of its clients, providing the advanced testing services they require, and assisting them in the establishment, implementation, and improvement of management systems. Within this framework, we also provide testing services compliant with the ISO 5833 standard.
To get an appointment, to get more detailed information or to request an evaluation, you can ask us to fill in our form and reach you.
